At-home ketamine therapy: what you're signing up for

At-home ketamine programs work like this. You complete a telehealth evaluation, a prescriber writes for compounded ketamine (usually lozenges or tablets you dissolve under your tongue), and a pharmacy ships it to your door. You take it on a schedule, sometimes with a virtual session or an app check-in attached. HealingMaps, a commercial clinic directory, puts the cost at about $200–$450 a month, against roughly $300–$800 for a single monitored infusion. The savings are real. What you give up is on-site monitoring, and the FDA has said plainly why that matters.

What the FDA said about compounded ketamine

In October 2023, the FDA issued a Compounding Risk Alert about compounded ketamine products, including oral and sublingual forms, used for psychiatric disorders. These are the products at-home programs prescribe. The FDA was specific. Ketamine is not FDA-approved for any psychiatric disorder. Compounded products have not been reviewed for safety, effectiveness, or quality. No safe or effective psychiatric dose has been established, and doses sold by compounders and telemedicine platforms vary. The risks it listed are sedation, dissociation, increases in blood pressure, respiratory depression (slowed breathing), psychiatric events, abuse and misuse, and bladder and urinary symptoms. At home, no clinician is there to respond to any of them. The FDA described a 2023 report of a patient whose breathing slowed dangerously after taking compounded oral ketamine outside a health care setting, with a blood level about twice what is typical during anesthesia.

The alert has limits, and they matter. It does not apply to Spravato®, which is FDA-approved and given under mandatory observation. Nor is it a finding that in-clinic IV ketamine is safe or effective for psychiatric use; the FDA said that benefit-risk profile is unknown. Its added concern is that at-home use removes on-site monitoring. Our safety page covers the full risk picture.

Why the model exists anyway

Access is the reason. If the nearest infusion clinic is two hours away, or six infusions at $600 each will not fit your budget, a $200-a-month program can look like the only option you have. That is a fair position. At-home treatment trades monitoring for access. Some programs manage that trade responsibly. Others are little more than a checkout page.

What a responsibly run program looks like

If you're going to do this, the difference between careful and careless is visible before you pay. Look for:

• A real psychiatric evaluation. That means a live video visit with a licensed prescriber who takes a full history, screens for the risks that matter (high blood pressure, aneurysm or other blood-vessel disease, a history of bleeding in the brain, psychosis or substance use history, and pregnancy), and can say no. An intake form that approves everyone isn't screening.
• A required sitter or check-in protocol. Someone should be present or reachable during sessions who knows the signs of slowed breathing and when to call 911. A careful program makes this a condition of treatment and tells you so up front.
• A home blood-pressure cuff, with readings before and after dosing. Good programs require it.
• Conservative dosing with hard limits: a small number of doses dispensed at a time, no "take extra if needed" language, and a plan for what happens to unused medication.
• Stopping rules. There should be a defined point where non-response ends the prescription instead of escalating it. Ketamine has genuine misuse potential; frequent, high-dose use is the pattern associated with bladder damage and dependence, documented mainly in recreational misuse.
• A path to a higher level of care. Ask how the program decides that someone needs in-person treatment instead, and what happens then. A program that cannot answer has left that decision to you.

Questions to ask before you pay

Who is the prescriber, and in what state are they licensed? How often do doses ship, and how many at a time? What happens if my blood pressure runs high or I have a frightening dissociative experience at home? Do you require a sitter? What's your protocol if I report worsening mood or thoughts of self-harm? If the answers are vague, or come from a chatbot, keep looking.

Ask about the legal footing too. Telehealth prescribing of ketamine without a prior in-person exam depends on temporary DEA and HHS flexibilities, currently extended through December 31, 2026. A program can be here today and unable to renew your prescription later, so ask what its plan is if the rules change.

Before you sign up

Supervised treatment is the safer default. If a monitored option, such as an infusion clinic or a Spravato center your insurance covers, is within reach, start there. Check the manufacturer's Find a Center tool and the other search tools we list under Finding programs to compare before assuming there's nothing near you. If at-home is the only option you can reach, choose the program by the quality of its screening. Your safety depends on it.